SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells

Autor: M. Svelto, Mario Capasso, Vincenzo La Mura, Daniela Spano, Roberto Torella, Claudio Tiribelli, Roberta Russo, Eliana Persico, Marcello Persico, Immacolata Andolfo, Achille Iolascon

Publikováno v: Clinical chemistry and laboratory medicine 47 (2009): 1217–1225. doi:10.1515/CCLM.2009.280
info:cnr-pdr/source/autori:Persico, Marcello; Russo, Roberta; Persico, Eliana; Svelto, Monica; Spano, Daniela; Andolfo, Immacolata; La Mura, Vincenzo; Capasso, Mario; Tiribelli, Claudio; Torella, Roberto; Iolascon, Achille/titolo:SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells/doi:10.1515%2FCCLM.2009.280/rivista:Clinical chemistry and laboratory medicine/anno:2009/pagina_da:1217/pagina_a:1225/intervallo_pagine:1217–1225/volume:47
Europe PubMed Central

Background: The poor response to antiviral treatment of hepatitis C virus (HCV)-infected patients with genotype 1b has been associated with a higher prevalence of metabolic syndrome. However, the molecular link between these clinical entities is not

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc514ce8d1a61f6bc8b36989ac2f58d6
http://edoc.hu-berlin.de/18452/10588